Patrice Wendling is a senior journalist for Medscape, specializing in medical news and research. With a focus on cardiology and cardiovascular diseases, Patrice covers the latest developments in treatments, clinical trials, and breakthroughs in the field. Her articles provide valuable insights and updates for healthcare professionals and researchers.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .
The US Food and Drug Administration approved opicapone , a once-daily peripheral catechol-O-methyltransferase (COMT) inhibitor, in 2020 as add-on
New phase 3 results should reopen discussion about the off-label use of COMT inhibitors in early Parkinson's disease, experts said.
September 17, 2014 | Dermatology Author and Disclosure Information EXPERT ANALYSIS FROM THE 15th WORLD CONGRESS ON CANCERS OF THE SKIN
December 1, 2005 | Dermatology Author and Disclosure Information
December 1, 2005 | Dermatology Author and Disclosure Information
August 27, 2014 | Dermatology Author and Disclosure Information EXPERT OPINION FROM THE AAD SUMMER ACADEMY 2014
June 22, 2012 | Rheumatology News Author and Disclosure Information AT THE ANNUAL MEETING OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Cardiac biomarkers vary according to sex hormones in healthy transgender adults, just as in cisgender individuals, a new cross-sectional study suggests.
Virtual platforms democratized scientific meetings during the COVID-19 pandemic but, as any meeting-goer will tell you, it's the questions from the floor and the back-and-forth of an expert panel that often reveal the importance of and/or problems with a presentation. It's the scrutiny that makes the science resonate, especially in this postfactual era.
(833) 317-6278 
